Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleBramham K, Lightstone L, 2012,
Pre-pregnancy counseling for women with chronic kidney disease
, JOURNAL OF NEPHROLOGY, Vol: 25, Pages: 450-459, ISSN: 1121-8428- Author Web Link
- Cite
- Citations: 35
-
Conference paperPinato DJ, Stavraka C, O'Cathail SM, et al., 2012,
Use of inflammation-based scores to optimize the selection of patients with advanced cancer considered for early-phase clinical trials
, 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: AMER SOC CLINICAL ONCOLOGY, ISSN: 0732-183X -
Conference paperBao T, Betts K, Tarpinian K, et al., 2012,
Changes in patient-reported outcomes in women with breast cancer in a multicenter double-blind randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms (AIMSS)
, 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Publisher: AMER SOC CLINICAL ONCOLOGY, ISSN: 0732-183X- Author Web Link
- Cite
- Citations: 1
-
Journal articleKyrgiou M, Stasinou SM, Arbyn M, et al., 2012,
Management of low-grade squamous intra-epithelial lesions of the uterine cervix: Repeat cytology versus immediate referral to colposcopy
, Cochrane Database of Systematic Reviews, Vol: 2012This is the protocol for a review and there is no abstract. The objectives are as follows: The aim of this review will be to assess whether women with low-grade squamous intra-epithelial lesions (LSILs) should be referred immediately to colposcopy or have repeat cytology.
-
Journal articleAdcock IM, Chung KF, Caramori G, et al., 2012,
Kinase inhibitors and airway inflammation (Retraction of vol 533, pg 118, 2006)
, EUROPEAN JOURNAL OF PHARMACOLOGY, Vol: 683, Pages: 340-340, ISSN: 0014-2999 -
Journal articleKwok H, Tong AHY, Lin CH, et al., 2012,
Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy
, PLOS ONE, Vol: 7, ISSN: 1932-6203- Author Web Link
- Cite
- Citations: 75
-
Journal articleReynolds N, Latos P, Hynes-Allen A, et al., 2012,
NuRD Suppresses Pluripotency Gene Expression to Promote Transcriptional Heterogeneity and Lineage Commitment
, CELL STEM CELL, Vol: 10, Pages: 583-594, ISSN: 1934-5909- Cite
- Citations: 183
-
Journal articleWalker NF, Clark SO, Oni T, et al., 2012,
Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases
, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 185, Pages: 989-997, ISSN: 1073-449X- Cite
- Citations: 116
-
Journal articleVan Calster B, Timmerman D, Valentin L, et al., 2012,
Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol.
, BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 119, Pages: 662-671, ISSN: 1470-0328Objective To compare guidelines from the Royal College of Obstetricians and Gynaecologists (RCOG) based on the Risk of Malignancy Index (RMI) with a protocol based on logistic regression model LR2 developed by the International Ovarian Tumour Analysis (IOTA) group for triaging women with an ovarian mass as low, moderate, or high risk of malignancy. Design and setting Observational diagnostic study conducted between 2005 and 2007 at 21 oncology referral centres, referral centres for ultrasonography and general hospitals. Sample In all, 1938 women undergoing surgery for an ovarian mass. Methods RCOG guidelines use the RMI to triage women as low (RMI < 25), moderate (25-250), or high (above > 250) risk. The IOTA protocol uses LR2s estimated probability of malignancy (< 0.05 indicates low risk, 0.05 but < 0.25 moderate risk, and 0.25 high risk). Main outcome measure Percentages of benign, borderline and invasive tumours classified as low, moderate or high risk. Results The IOTA and RCOG protocols classified 71.1% and 62.1% of benign tumours as low risk, respectively (difference 9.0; 95% CI 6.2-11.9, P < 0.0001). Of invasive tumours, 88.6% and 73.6% were labelled high risk (difference 15.0; 10.6-19.4, P < 0.0001), and 3.0% and 5.2% were labelled low risk (difference) 2.2;) 4.6 to 0.2, P = 0.07) respectively by each protocol. Similar results were found after stratification for menopausal status. Conclusions The IOTA protocol was more accurate for triage than the RCOG protocol. The IOTA protocol would avoid major surgery for more women with benign tumours while still appropriately referring more women with an invasive tumour to a gynaecological oncologist.
-
Journal articleCalderon MA, Penagos M, Sheikh A, et al., 2012,
Sublingual immunotherapy for treating allergic conjunctivitis
, Evidence Based Child Health, Vol: 7, Pages: 1041-1154Background: Allergic ocular symptoms, although frequently trivialised, are common and represent an important comorbidity of allergic rhinitis. Sublingual Immunotherapy (SLIT) is an effective and well-tolerated treatment for allergic rhinitis, but its effects on symptoms of ocular allergy have not been well established. Objectives: To evaluate the efficacy of SLIT compared with placebo for reductions in ocular symptoms, topical ocular medication requirements and conjunctival immediate allergen sensitivity. Search methods: We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (The Cochrane Library 2011, Issue 1), MEDLINE (January 1950 to January 2011), EMBASE (January 1980 to January 2011), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to January 2011), Web of Science (January 1970 to January 2011), Biosis Previews, (January 1979 to January 2011), the metaRegister of Controlled Trials (mRCT) (www.controlled-trials.com) (January 2011), ClinicalTrials.gov (www.clinicaltrials.gov) (January 2011), the Australian New Zealand Clinical Trials Registry (ANZCTR) (www.actr.org.au) (July 2010), SCOPUS (November 2008) and the UK Clinical Trials Gateway (January 2010). There were no language or date restrictions in the search for trials. All electronic databases except for SCOPUS, the UK Clinical Trials Gateway and ANZCTR were last searched on 19 January 2011. Selection criteria: Randomised controlled trials (RCTs), double-masked and placebo controlled, which evaluated the efficacy of SLIT in patients with symptoms of allergic rhinoconjunctivitis (ARC) or allergic conjunctivitis (AC). Data collection and analysis: The primary outcome was the total ocular symptom scores. Secondary endpoints included individual ocular symptom scores (such as itchy eyes, red eyes, watery eyes, swollen eyes), ocular medication scores (eye drops) and conjunctival immediate allergen sensitivity (CIAS). Data were analysed and reported
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.